This inventor holds 1 USPTO granted patent. Top assignees: Institut Organicheskoi Khimii Akademii Nauk Ukrainskoi Ssr, Kievsky Nauchno-Issledovatelsky Institut Otolaringologii. Active years: 1985.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1985
Title: Evgeny I Klochkov: Innovator in Pharmaceutical Chemistry
Introduction
Evgeny I Klochkov is a notable inventor based in Kyiv, Ukraine. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on novel compounds with potential therapeutic applications. His research has focused on the development of compounds that exhibit immunomodulating, antibacterial, and antiviral activities.
Latest Patents
Klochkov holds a patent for a unique class of compounds known as 6-Phenyl-2,3,5,6-tetrahydroimidazo-[2,1-b]-thiazole derivatives. This patent includes the general formula wherein R can be CH₂ COOCH₃, CH₂ COOC₁₀H₂₁, or CH₂ CONH₂, with X being Br. These compounds are recognized for their promising biological activities, which could lead to advancements in medical treatments.
Career Highlights
Throughout his career, Klochkov has been associated with prestigious institutions such as the Institute of Organic Chemistry of the Academy of Sciences of the Ukrainian SSR and the Kyiv Scientific Research Institute of Otolaryngology. His work in these organizations has allowed him to explore various aspects of organic chemistry and its applications in medicine.
Collaborations
Klochkov has collaborated with esteemed colleagues, including Eduard V Gjulling and Larisa A Djugovskaya. These partnerships have enriched his research and contributed to the development of innovative solutions in the field of pharmaceutical chemistry.
Conclusion
Evgeny I Klochkov's contributions to the field of pharmaceutical chemistry through his patented compounds highlight his role as an influential inventor. His work continues to inspire advancements in medical research and therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile